Consequently, we propose that CDC6 may play a pivotal role in promoting immune infiltration during the progression from PCOS to endometrial cancer, which not only has the potential to elucidate a significant connection between these two gynecological disorders but also offers new theoretical insights for immune-targeted therapies. Here, CDC6 is linked to polycystic ovary syndrome.